NEW YORK (GenomeWeb) – A negative coverage recommendation proposed by the Oregon Health Authority could restrict access to next-generation sequencing tumor profiling for some of the most vulnerable residents in the state, cancer patient advocates fear.

Get the full story withGenomeWeb Premium Only $95 for thefirst 90 days*